OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
South San Francisco
Gregory S. Blank is the director of late-stage purification at Genentech, Inc.
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.